Recent Headlines
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH
NuvOx Pharma Awarded STTR Grant from NCI for Ultrasound Contrast Agent to Diagnose Pancreatic Cancer
Evan Unger, MD, President and CEO of NuvOx Pharma, a Tucson based biotechnology company, announced that the company has been awarded a grant from the National Cancer Institute to develop an ultrasound contrast agent to diagnose pancreatic cancer. The Phase I Small Business Technology Transfer... - May 28, 2016 - NuvOx Pharma
MoBiTec GmbH Teams Up with TargetMol, US, to Offer Thousands of Inhibitors and Predetermined Screening Libraries
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS). - May 25, 2016 - MoBiTec GmbH
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
Now Available: A Red-Fluorescent cADDis Assay Kit, Manufactured by Montana Molecular, for Measuring cAMP Changes in Live Mammalian Cells
Cyclic AMP (cAMP) is the prototypical second messenger. The major receptor in eukaryotic cells, cAMP-dependent Protein Kinase (PKA), is ubiquitous. cAMP affects many different physiological and biochemical processes, including the activity of kinases. In contrast to the hitherto available green-fluorescent cADDis kit, the red-fluorescent counterpart can be used in combination with green-fluorescent gene constructs, such as GFP, or ion indicators. - May 19, 2016 - MoBiTec GmbH
National Brain Tumor Society Statement on Revised World Health Organization Classification of Tumors of the Central Nervous System
National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today released the following statement from David F. Arons, Chief Executive Officer, on the publishing of the 2016 updated World Health Organization (WHO) Classification of... - May 12, 2016 - National Brain Tumor Society
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
Pediatric Brain Tumor Foundation's New Campaign Aims to Raise Awareness in May and Every Day
The Pediatric Brain Tumor Foundation believes the conversation about brain tumors is bigger than just one month. That’s why the world's largest nonprofit funder of childhood brain tumor research is kicking off Brain Tumor Awareness Month with the “May and Every Day” campaign. - May 02, 2016 - Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation Introduces Free Toolkit for Newly Diagnosed Families
The Pediatric Brain Tumor Foundation is pleased to announce the publication of the Star Portfolio, a new resource for families of children recently diagnosed with a brain tumor. “Our new Star Portfolio is a toolkit designed to help families of newly diagnosed brain tumor patients partner... - April 28, 2016 - Pediatric Brain Tumor Foundation
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
Arteric Appoints New Director of Technology Fast-Growing Pharmaceutical and Biotechnology Digital Agency Broadens Its Digital Healthcare Capabilities with 15-Year Veteran
Arteric is pleased to announce that Jon Fisher has joined Arteric as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency. - April 15, 2016 - Arteric
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Arteric Appoints New Group Account Supervisor; Fast-Growing Pharmaceutical and Biotechnology Digital Agency Strengthens Account Services
Arteric (http://arteric.com) is excited to introduce Heather Eckhaus as its new Group Account Supervisor. Heather joins Arteric from DigitasLBi in New York, where she led the Pitney Bowes account, with key initiatives including the global redesign and rebuild of pitneybowes.com as well as the... - April 11, 2016 - Arteric
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Pharma
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Pharma
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Pharma
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme
F2G Ltd, a UK based antifungal drug discovery and development company, today announced that its novel systemic antifungal product F901318 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways pilot programme. Initiated in March 2014, the Adaptive... - December 03, 2015 - F2G Ltd
Update on Glycomics - Achieve Safe, Easy, and Accurate O-Glycan Analysis with BlotGlyco® O-Glycan Sample Preparation Kit
MoBiTec to launch Sumitomo's BlotGlyco® O-Glycan Sample Preparation Kit, a streamlined process for releasing and purifying O-glycans for detection by HPLC, LC-MS, and MALDI-TOF MS. - November 19, 2015 - MoBiTec GmbH
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
PBTF, ABC2 Cofund Pediatric Brain Cancer Screening Research
The Pediatric Brain Tumor Foundation and ABC2 (Accelerate Brain Cancer Cure) are working together to fund the development of immunosignature-based blood tests for detecting, classifying and monitoring pediatric medulloblastoma over time. - November 04, 2015 - Pediatric Brain Tumor Foundation
RxGenesys, LLC. Validates Claims via Double Blind Independent Study by Princeton Consumer Research
RxGenesys Complete Skin Care System(R) Reduces Fine Lines and wrinkles by 56% and Improves Radiance, Elasticity and Moisture Levels After Eight Weeks. Watch the interview at: http://youtu.be/9RySXfUbm3s RxGenesys, a developer, manufacturer and marketer of state-of-the-art skin care, based on a... - October 30, 2015 - RxGenesys
New Sealed Tubing Ends from AdvantaPure(R) Reduce Operational Costs and Improve Efficiencies; Help to Maintain a Sterile and Closed Fluid Transfer System
Now available from AdvantaPure is its AdvantaFlex(R) biopharmaceutical grade tubing with pre-sealed ends. The ends maintain a closed, sterile fluid path system for sampling and storage uses in biopharma and pharmaceutical applications. Sealed Tubing Ends save time compared to sealing on site and reduce the need for expensive aseptic connectors. The Single-Use product is supplied gamma sterilized and ready for immediate use in both upstream and downstream applications. - October 29, 2015 - AdvantaPure
Pregmama Announces First Pregnancy in Its Pilot Clinical Trial to Treat Infertility in Women Over 35
Rolling back the clock on infertility - October 22, 2015 - Pregmama LLC
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Northern California Motorcyclists Ride for Kids with Brain Tumors
Nearly 200 motorcyclists gathered for the Northern California Ride for Kids over the weekend to support children battling brain tumors. As of ride time, the family-friendly motorcycle event in Fairfield, Calif., had raised $59,342 to support the Pediatric Brain Tumor Foundation. The event honored... - October 07, 2015 - Pediatric Brain Tumor Foundation
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs